219 related articles for article (PubMed ID: 36992374)
1. Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study.
Costa VGD; Gomes AJC; Bittar C; Geraldini DB; Previdelli da Conceição PJ; Cabral ÁS; Carvalho T; Biselli JM; Provazzi PJS; Campos GRF; Sanches PRDS; Costa PI; Nogueira ML; Araujo JP; Spilki FR; Calmon MF; Rahal P
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992374
[TBL] [Abstract][Full Text] [Related]
2. Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021.
Moumbeket Yifomnjou MH; Monamele GC; Njankouo-Ripa M; Fatawou Modiyinji A; Ngoupo PA; Boyomo O; Njouom R
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13131. PubMed ID: 36991539
[TBL] [Abstract][Full Text] [Related]
3. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis.
Cong B; Deng S; Wang X; Li Y
J Glob Health; 2022 Sep; 12():05040. PubMed ID: 36112521
[TBL] [Abstract][Full Text] [Related]
4. Resurgence of influenza and respiratory syncytial virus in Egypt following two years of decline during the COVID-19 pandemic: outpatient clinic survey of infants and children, October 2022.
Kandeel A; Fahim M; Deghedy O; Roshdy WH; Khalifa MK; Shesheny RE; Kandeil A; Naguib A; Afifi S; Mohsen A; Abdelghaffar K
BMC Public Health; 2023 Jun; 23(1):1067. PubMed ID: 37277781
[TBL] [Abstract][Full Text] [Related]
5. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
Mohebi L; Karami H; Mirsalehi N; Ardestani NH; Yavarian J; Mard-Soltani M; Mokhatri-Azad T; Salimi V
J Med Virol; 2022 Dec; 94(12):5802-5807. PubMed ID: 35961780
[TBL] [Abstract][Full Text] [Related]
6. Tracking severe acute respiratory syndrome coronavirus 2 transmission and co-infection with other acute respiratory pathogens using a sentinel surveillance system in Rift Valley, Kenya.
Ruttoh VK; Symekher SL; Majanja JM; Opanda SM; Chitechi EW; Wadegu M; Tonui R; Rotich PK; Nyandwaro TT; Mwangi AW; Mwangi IN; Oira RM; Musimbi AG; Nzou SM
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13227. PubMed ID: 38019696
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.
Hashemi SA; Safamanesh S; Ghasemzadeh-Moghaddam H; Ghafouri M; Azimian A
J Med Virol; 2021 Feb; 93(2):1008-1012. PubMed ID: 32720703
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and trends in mono- and co-infection of COVID-19, influenza A/B, and respiratory syncytial virus, January 2018-June 2023.
Lee MK; Alfego D; Dale SE
Front Public Health; 2023; 11():1297981. PubMed ID: 38162614
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre.
Quarg C; Jörres RA; Engelhardt S; Alter P; Budweiser S
Eur J Med Res; 2023 Dec; 28(1):568. PubMed ID: 38053110
[TBL] [Abstract][Full Text] [Related]
10. Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV.
Weidmann MD; Green DA; Berry GJ; Wu F
Front Cell Infect Microbiol; 2023; 13():1208235. PubMed ID: 37389220
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?
Estofolete CF; Banho CA; Verro AT; Gandolfi FA; Dos Santos BF; Sacchetto L; Marques BC; Vasilakis N; Nogueira ML
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766255
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus and influenza surveillance in schoolchildren seen at a children's hospital over 2 months of the second semester of 2021.
Orqueda AS; Lucion MF; Juárez MV; Barquez R; Stach P; Nievas A; Losi LF; Suárez RF; Romero Bollón L; Pejito MN; Mistchenko AS; Gentile Á
Arch Argent Pediatr; 2022 Aug; 120(4):269-273. PubMed ID: 35900954
[TBL] [Abstract][Full Text] [Related]
14. Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain.
Ambrosch A; Luber D; Klawonn F; Kabesch M
J Clin Virol; 2023 Apr; 161():105399. PubMed ID: 36863135
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort.
Dietz E; Pritchard E; Pouwels K; Ehsaan M; Blake J; Gaughan C; Haduli E; Boothe H; Vihta KD; Peto T; Stoesser N; Matthews P; Taylor N; Diamond I; Studley R; Rourke E; Birrell P; De Angelis D; Fowler T; Watson C; Eyre D; House T; Walker AS
BMC Med; 2024 Mar; 22(1):143. PubMed ID: 38532381
[TBL] [Abstract][Full Text] [Related]
16. Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil.
Fröhlich GC; Gregianini TS; Pinheiro FG; Nascimento R; Cezar TM; Pscheidt VM; Selayaran T; Martins LG; Gomes MFDC; Salvato RS; Pereira EC; Guimarães-Ribeiro V; Scalioni LP; Siqueira MM; Resende PC; Veiga ABG;
J Med Virol; 2024 Mar; 96(3):e29551. PubMed ID: 38506236
[TBL] [Abstract][Full Text] [Related]
17. Resurgence of respiratory syncytial virus infection during COVID-19 pandemic in Pune, India.
Bhardwaj S; Choudhary ML; Chadha MS; Kinikar A; Bavdekar A; Gujar N; Dcosta P; Kulkarni R; Bafna S; Salvi S; Padbidri V; Potdar V
BMC Infect Dis; 2024 Jun; 24(1):586. PubMed ID: 38877428
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study.
Hedberg P; Karlsson Valik J; Abdel-Halim L; Alfvén T; Nauclér P
Clin Infect Dis; 2024 Apr; 78(4):900-907. PubMed ID: 37883521
[TBL] [Abstract][Full Text] [Related]
19. Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study.
Boehm AB; Hughes B; Duong D; Chan-Herur V; Buchman A; Wolfe MK; White BJ
Lancet Microbe; 2023 May; 4(5):e340-e348. PubMed ID: 36965504
[TBL] [Abstract][Full Text] [Related]
20. Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay.
Domnich A; Bruzzone B; Trombetta CS; De Pace V; Ricucci V; Varesano S; Garzillo G; Ogliastro M; Orsi A; Icardi G
J Clin Virol; 2023 Apr; 161():105402. PubMed ID: 36805601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
